(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/A4Cx4gDTk7e.png?ph=true&h=300&w=458 "(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | A4Cx4gDTk7e |
|---|---|
| InChI | InChI=1S/C18H26N4O/c1-5-16(20-21-19)15-12-18(15,17(23)22(6-2)7-3)14-10-8-9-13(4)11-14/h8-11,15-16H,5-7,12H2,1-4H3/t15-,16-,18+/m0/s1 |
| InChIKey | BXLOMPJNWJGPGL-XYJFISCASA-N |
| Mol Weight | 314.43 g/mol |
| Molecular Formula | C18H26N4O |
| Exact Mass | 314.210661 g/mol |
| Enantiomer InChIKey | BXLOMPJNWJGPGL-NUJGCVRESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
N-[2-(4,4-diphenyl-1-isopropyl-5-oxo-3-pyrrolidinyl)ethyl]phthalimide
(1S,2R)-1-(1-NAPHTHYL)-2-FORMYL-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
1-ETHYL-4-(2-MORPHOLINOETHYL)-3-PHENYL-3-(3-PYRIDYL)-2-PYRROLIDINONE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
2,4-Imidazolidinedione, 3-ethyl-5-phenyl-5-[3-[(trimethylsilyl)oxy]phenyl]-
3-CYCLOPENTYL-1-ISOPROPYL-4-(2-MORPHOLINOETHYL)-3-PHENYL-2-PYRROLIDINONE, MALEATE (1:1)
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |